PACT Pharma Funding & Investors
PACT Pharma, Inc. operates as a biotechnology company. The Company develops personalized adoptive cell therapies designed for the eradication of solid tumors. PACT Pharma focuses on re-programming immune system to target and to eradicate the cancer. PACT Pharma serves customers in the State of California.
pactpharma.comTotal Amount Raised: $200,000,000
PACT Pharma Funding Rounds
Series C
$75,000,000
Series C Investors
Vida VenturesPontifaxWu CapitalForesite CapitalZhejiang Canaan TechnologyTaiho VenturesGVDroia VenturesCasdin CapitalAbbVie Biotech VenturesInvus OpportunitiesSeries B
$95,000,000
Series B Investors
GVCanaan PartnersInvusCasdin CapitalUpHonest CapitalWei GuoSeries A
$30,000,000
Series A Investors
GV
Funding info provided by Diffbot.